ERBB2 promoter binding protein in neoplastic disease


Ontology type: sgo:Patent     


Patent Info

DATE

1996-05-21T00:00

AUTHORS

RAZIUDDIN , Fazlul H. Sarkar

ABSTRACT

The present invention provides a purified and isolated DNA-binding protein, HPBF, which specifically binds to the promoter region of the Her-2/neu (ERBB2/c-erbB-2) gene sequence, the presence of which provides an early indication of transition to a cancerous state has been found. The present invention also provides bioassays for screening substances for the ability to inhibit HPBF activity, the ability to inhibit the mitogenic activity of HPBF and the ability to inhibit HPBF production. The present invention further provides methods of inhibiting the biological activity mediated by HPBF comprising preventing the HPBF from binding to the promoter region of the ERBB2 gene sequence. More... »

Related SciGraph Publications

  • 1988-10. c-erbB-2 expression in benign and malignant breast disease in BRITISH JOURNAL OF CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2620", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "name": "RAZIUDDIN", 
            "type": "Person"
          }, 
          {
            "name": "Fazlul H. Sarkar", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1128/mcb.11.4.1875", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004178925"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/nar/12.23.8779", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004223950"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.1988.239", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019424593", 
              "https://doi.org/10.1038/bjc.1988.239"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.1988.239", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019424593", 
              "https://doi.org/10.1038/bjc.1988.239"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.83.2.261", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030989042"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0092-8674(85)90113-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045091546"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1073/pnas.84.23.8498", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048122735"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1996-05-21T00:00", 
        "description": "

    The present invention provides a purified and isolated DNA-binding protein, HPBF, which specifically binds to the promoter region of the Her-2/neu (ERBB2/c-erbB-2) gene sequence, the presence of which provides an early indication of transition to a cancerous state has been found. The present invention also provides bioassays for screening substances for the ability to inhibit HPBF activity, the ability to inhibit the mitogenic activity of HPBF and the ability to inhibit HPBF production. The present invention further provides methods of inhibiting the biological activity mediated by HPBF comprising preventing the HPBF from binding to the promoter region of the ERBB2 gene sequence.

    ", "id": "sg:patent.US-5518885-A", "keywords": [ "promoter binding", "neoplastic disease", "invention", "DNA-Binding Protein", "Genetic Promoter Region", "HER-2/neu", "ErbBs", "gene sequence", "early indication", "transition", "cancerous state", "Biological Assay", "substance", "mitogenic activity", "method", "biological activity", "preventing", "binding" ], "name": "ERBB2 promoter binding protein in neoplastic disease", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.420176.6", "type": "Organization" }, { "id": "https://www.grid.ac/institutes/grid.27235.31", "type": "Organization" }, { "id": "https://www.grid.ac/institutes/grid.254444.7", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-5518885-A" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:26", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_03020.jsonl", "type": "Patent" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-5518885-A'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-5518885-A'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-5518885-A'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-5518885-A'


     

    This table displays all metadata directly associated to this object as RDF triples.

    67 TRIPLES      15 PREDICATES      40 URIs      26 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:patent.US-5518885-A schema:about anzsrc-for:2620
    2 schema:author N2b7a201d6feb41ebaf85ca40c5c3e511
    3 schema:citation sg:pub.10.1038/bjc.1988.239
    4 https://doi.org/10.1016/0092-8674(85)90113-8
    5 https://doi.org/10.1073/pnas.83.2.261
    6 https://doi.org/10.1073/pnas.84.23.8498
    7 https://doi.org/10.1093/nar/12.23.8779
    8 https://doi.org/10.1128/mcb.11.4.1875
    9 schema:datePublished 1996-05-21T00:00
    10 schema:description <p>The present invention provides a purified and isolated DNA-binding protein, HPBF, which specifically binds to the promoter region of the Her-2/neu (ERBB2/c-erbB-2) gene sequence, the presence of which provides an early indication of transition to a cancerous state has been found. The present invention also provides bioassays for screening substances for the ability to inhibit HPBF activity, the ability to inhibit the mitogenic activity of HPBF and the ability to inhibit HPBF production. The present invention further provides methods of inhibiting the biological activity mediated by HPBF comprising preventing the HPBF from binding to the promoter region of the ERBB2 gene sequence.</p>
    11 schema:keywords Biological Assay
    12 DNA-Binding Protein
    13 ErbBs
    14 Genetic Promoter Region
    15 HER-2/neu
    16 binding
    17 biological activity
    18 cancerous state
    19 early indication
    20 gene sequence
    21 invention
    22 method
    23 mitogenic activity
    24 neoplastic disease
    25 preventing
    26 promoter binding
    27 substance
    28 transition
    29 schema:name ERBB2 promoter binding protein in neoplastic disease
    30 schema:recipient https://www.grid.ac/institutes/grid.254444.7
    31 https://www.grid.ac/institutes/grid.27235.31
    32 https://www.grid.ac/institutes/grid.420176.6
    33 schema:sameAs https://app.dimensions.ai/details/patent/US-5518885-A
    34 schema:sdDatePublished 2019-04-18T10:26
    35 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    36 schema:sdPublisher Ncd6f5b68d4e146ee8afa7952e0eecd2e
    37 sgo:license sg:explorer/license/
    38 sgo:sdDataset patents
    39 rdf:type sgo:Patent
    40 N2b7a201d6feb41ebaf85ca40c5c3e511 rdf:first Nc5280b13f58141289cdeffb34d1834e3
    41 rdf:rest Ndfee76fcde4a498489680c727ef16fb6
    42 N330c322e6f254146aaab0e103189a81c schema:name Fazlul H. Sarkar
    43 rdf:type schema:Person
    44 Nc5280b13f58141289cdeffb34d1834e3 schema:name RAZIUDDIN
    45 rdf:type schema:Person
    46 Ncd6f5b68d4e146ee8afa7952e0eecd2e schema:name Springer Nature - SN SciGraph project
    47 rdf:type schema:Organization
    48 Ndfee76fcde4a498489680c727ef16fb6 rdf:first N330c322e6f254146aaab0e103189a81c
    49 rdf:rest rdf:nil
    50 anzsrc-for:2620 schema:inDefinedTermSet anzsrc-for:
    51 rdf:type schema:DefinedTerm
    52 sg:pub.10.1038/bjc.1988.239 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019424593
    53 https://doi.org/10.1038/bjc.1988.239
    54 rdf:type schema:CreativeWork
    55 https://doi.org/10.1016/0092-8674(85)90113-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045091546
    56 rdf:type schema:CreativeWork
    57 https://doi.org/10.1073/pnas.83.2.261 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030989042
    58 rdf:type schema:CreativeWork
    59 https://doi.org/10.1073/pnas.84.23.8498 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048122735
    60 rdf:type schema:CreativeWork
    61 https://doi.org/10.1093/nar/12.23.8779 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004223950
    62 rdf:type schema:CreativeWork
    63 https://doi.org/10.1128/mcb.11.4.1875 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004178925
    64 rdf:type schema:CreativeWork
    65 https://www.grid.ac/institutes/grid.254444.7 schema:Organization
    66 https://www.grid.ac/institutes/grid.27235.31 schema:Organization
    67 https://www.grid.ac/institutes/grid.420176.6 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...